This FDA funding opportunity supports research focused on evaluating the cutaneous pharmacokinetics of topical drug products using pharmacokinetic tomography. The grant requires conducting a U01 clinical trial. Specific eligibility and funding amount details are not provided in the listing.
Eligibility details are not specified in the grant listing. Contact the funding organization for requirements.
